Archive ouverte UNIGE (University of Geneva) · 2022 · 41 citations · 13 references
Life SciencesNeurologyNeuroscienceDementiaImmunotherapyNeuroimmunologyAlzheimer DiseaseCerebrovascular DiseaseCerebrovascular ImagingNeurodegenerative DiseasesNeurodegenerative DisordersStrokeAlzheimer Disease Vascular PathologyAmyloid Beta PlaquesAmyloid Beta-targeted TherapyAmyloid PlaquesVascular Amyloid DepositionVascular Amyloidosis
We review the implications of the recently approved aducanumab amyloid-β immunotherapy for treating Alzheimer disease with comorbid cerebral amyloid angiopathy. In clinical trials, amyloid-β immunotherapy has been associated with a high rate of amyloid-related imaging abnormalities, potentially driven by coexisting cerebral amyloid angiopathy. Therefore, immunotherapy's efficacy in patients may be modified by coexisting cerebrovascular pathology. We discuss the contributions of cerebral amyloid angiopathy on the development of amyloid-related imaging abnormalities and propose strategies to identify cerebral amyloid angiopathy in patients considered for immunotherapy.
13
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Neurology, Pharmacology +17
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
J. M. Orgogozo, S. Gilman, Jean‐François Dartigues et al. · Neurology · 2003 · 1.3K citations